Keith A. Bostian, Ph.D.
Keith Bostian is an entrepreneur scientist with a distinguished career in industry and academia. He is currently the Dean of NJ Center for Science, Technology & Mathematics and Technology and Office of Technology Commercialization at Kean University, and a founder and CEO of the Institute for Life Science Entrepreneurship. He has held senior executive positions in numerous life science companies including Kemin Industries, as President and CEO of the European pharma subsidiary and Vanta Bioscience. He was a founder of Mpex Pharmaceuticals, founder and CEO of Iconix Pharmaceuticals, and founder and COO of Microcide Pharmaceuticals. At Merck, he was Head of Microbiology and Molecular Genetics, with responsibility for antimicrobial drug discovery and discovery of new leads from natural products worldwide.
Dr. Bostian is an inventor on numerous patents in drug discovery and genomics, and has led efforts resulting in numerous clinical candidates including a first-in-class anti-fungal antibiotic, CANCIDAS®, and an aerosol fluoroquinolone, Aeroquin®, for cystic fibrosis infections, and has led development and launch of a proprietary probiotic, Anaban™. He is a fellow of the American Academy for Microbiology, and was a member of the faculty at Brown University.
Dr. Bostian earned his doctorate in Biochemistry from the University of London and was an American Cancer Society Postdoctoral Fellow.
Dr. Bostian is an inventor on numerous patents in drug discovery and genomics, and has led efforts resulting in numerous clinical candidates including a first-in-class anti-fungal antibiotic, CANCIDAS®, and an aerosol fluoroquinolone, Aeroquin®, for cystic fibrosis infections, and has led development and launch of a proprietary probiotic, Anaban™. He is a fellow of the American Academy for Microbiology, and was a member of the faculty at Brown University.
Dr. Bostian earned his doctorate in Biochemistry from the University of London and was an American Cancer Society Postdoctoral Fellow.